Dopaminergic and non-dopaminergic effects on instrumented timed up and go test in patients with Parkinson's disease

被引：0

|

作者：

Dibilio, V.

Nicoletti, A.

Mostile, G.

Toscano, S.

Luca, A.

Raciti, L.

Vasta, R.

Cicero, C. E.

Contrafatto, D.

Zappia, M.

机构：

来源：

MOVEMENT DISORDERS | 2016年 / 31卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

1537

引用

收藏

页码：S505 / S506

页数：2

相关论文

共 50 条

[21] Is there room for new non-dopaminergic treatments in Parkinson’s disease?
Manuela Pilleri
Konstantinos Koutsikos
Angelo Antonini
[J]. Journal of Neural Transmission, 2013, 120 : 349 - 352
[22] Treatment of Parkinson’s Disease: What’s in the Non-dopaminergic Pipeline?
Albert Y. Hung
Michael A. Schwarzschild
[J]. Neurotherapeutics, 2014, 11 : 34 - 46
[23] Anxiety in Parkinson's: a complex syndrome of non-dopaminergic and dopaminergic etiology
Pontone, G. M.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 (04) : 541 - 542
[24] Natural history of RBD in Parkinson's disease and response to dopaminergic and non-dopaminergic antiparkinsonian treatment
Ruiz-Lopez, M.
Bruno, V.
Freitas, M. E.
Rajalingam, R.
Chang, A.
Fox, S.
Lang, A.
[J]. MOVEMENT DISORDERS, 2018, 33 : S737 - S737
[25] Arm Swing May Reflect Both Dopaminergic and Non-Dopaminergic Dysfunction in Parkinson's Disease
Sterling, Nicholas W.
Cusumano, Joseph P.
Shaham, Noam
Piazza, Stephen J.
Liu, Guodong
Kong, Lan
Du, Guangwei
Lewis, Mechelle M.
Huang, Xuemei
[J]. ANNALS OF NEUROLOGY, 2014, 76 : S48 - S48
[26] Effect of adjunct rasagiline on dopaminergic and non-dopaminergic motor features of Parkinson's disease (PD)
Rabey, J. M.
Fitzer-Attas, C. J.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 64 - 64
[27] The Impact of Non-dopaminergic Medication on Quality of Life in Parkinson’s Disease
Nicol G. M. Oonk
Kris L. L. Movig
Job van der Palen
Henk-Willem Nijmeijer
Mirjam E. van Kesteren
Lucille D. A. Dorresteijn
[J]. Clinical Drug Investigation, 2021, 41 : 809 - 816
[28] Erratum to: Non-dopaminergic Treatments for Motor Control in Parkinson’s Disease
Susan H. Fox
[J]. Drugs, 2014, 74 : 1305 - 1305
[29] Exploring therapeutic viability of a non-dopaminergic target for Parkinson's disease
Ashrafi, A.
Buttini, M.
Garcia, P.
del Sol, A.
Glaab, E.
[J]. MOVEMENT DISORDERS, 2016, 31 : S630 - S630
[30] Non-dopaminergic treatment of Parkinson's disease -: Guest editors' introduction
Przuntek, H
Müller, T
[J]. JOURNAL OF NEUROLOGY, 2000, 247 : 2 - 2

← 1 2 3 4 5 →